Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook > Product Catalogue >Chemical Reagents >Organic reagents >Boric acid >4-Isoquinolineboronic acid

4-Isoquinolineboronic acid

4-Isoquinolineboronic acid Structure
  • ₹0
  • Product name: 4-Isoquinolineboronic acid
  • CAS: 192182-56-2
  • MF: C9H8BNO2
  • MW: 172.98
  • EINECS:
  • MDL Number:MFCD03839356
  • Synonyms:CHEMBRDG-BB 4002849;ISOQUINOLIN-5-YLBORONIC ACID;ISOQUINOLIN-4-YLBORONIC ACID;ISOQUINOLINE-4-BORONIC ACID;4-ISOQUINOLINEBORONIC ACID;4-ISOQUINOLINYLBORONI ACID;AKOS BRN-0121;AKOS BRN-0458
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Melting point :178°C
Boiling point :419.1±37.0 °C(Predicted)
Density :1.28±0.1 g/cm3(Predicted)
storage temp. :2-8°C
form :solid
pka :4.61±0.30(Predicted)
color :White to off-white
CAS DataBase Reference :192182-56-2(CAS DataBase Reference)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P304+P340 IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P405 Store locked up.

Description

4-Isoquinolineboronic acid is a reactant for preparation of selective steroid-11β-hydroxylase (CYP11B1) inhibitors, tetrabutylammonium trifluoroborates and heteroaryl substituted tetrahydropyrroloijquinolinone derivatives as aldosterone synthase inhibitors.

Related product price